{
    "hands_on_practices": [
        {
            "introduction": "The cornerstone of diagnosing atypical parkinsonian syndromes is the ability to synthesize a complex array of clinical information into a coherent diagnostic hypothesis. This practice problem challenges you to act as a clinical detective, weaving together details from the patient's history, key neuro-ophthalmologic and motor examination findings, and characteristic imaging results. Honing this skill is fundamental to accurately distinguishing Progressive Supranuclear Palsy from its primary mimics and setting appropriate patient expectations.",
            "id": "4449677",
            "problem": "A $68$-year-old person presents with a $2$-year history of progressively worsening slowness of movement and stiffness. The onset was insidious and symmetrical, with predominantly axial rigidity and marked gait instability. Within the first $6$ months, the patient sustained multiple unexplained backward falls despite no significant peripheral neuropathy or cerebellar ataxia on examination. There is hypophonia, spastic-appearing dysarthria, and a mild, low-amplitude postural tremor without a classic resting tremor. Neuro-ophthalmologic examination reveals markedly slowed vertical saccades and impaired voluntary upgaze and downgaze, yet the vestibulo-ocular (oculocephalic) reflex is preserved. A standardized levodopa trial at $800$ mg/day over $8$ weeks yielded minimal clinical improvement. Autonomic testing demonstrates no orthostatic hypotension exceeding a systolic blood pressure drop of $10$ mmHg and no urinary retention requiring catheterization. Magnetic Resonance Imaging (MRI) shows disproportionate midbrain atrophy with relative pontine preservation, producing a so-called “hummingbird” appearance; there is no “hot-cross bun” sign in the pons, and no marked putaminal rim hyperintensity. There are no cortical sensory deficits, no limb apraxia, and no alien limb phenomena. There is no stepwise progression, and brain MRI lacks confluent subcortical ischemic changes.\n\nUsing core definitions and well-tested facts about parkinsonian syndromes, classify the most likely diagnosis and justify your choice based on defining features that differentiate the major atypical parkinsonian syndromes from idiopathic Parkinson’s Disease (PD). Choose the single best option.\n\nA. Progressive Supranuclear Palsy (PSP), Richardson syndrome phenotype\n\nB. Parkinson’s Disease (PD)\n\nC. Multiple System Atrophy–parkinsonian type (MSA-P)\n\nD. Corticobasal Degeneration (CBD)\n\nE. Vascular parkinsonism",
            "solution": "The problem statement describes a clinical case and asks for the most likely diagnosis from a list of parkinsonian syndromes. The first step is to validate the problem statement.\n\n### PROBLEM VALIDATION\n\n**Step 1: Extract Givens**\n- **Patient Demographics:** $68$-year-old person.\n- **History of Present Illness:** $2$-year history of progressively worsening slowness of movement and stiffness.\n- **Motor Symptoms:**\n    - Insidious and symmetrical onset.\n    - Predominantly axial rigidity.\n    - Marked gait instability.\n    - Multiple unexplained backward falls within the first $6$ months of onset.\n    - Mild, low-amplitude postural tremor; no classic resting tremor.\n- **Speech:** Hypophonia and spastic-appearing dysarthria.\n- **Neuro-ophthalmology:**\n    - Markedly slowed vertical saccades.\n    - Impaired voluntary upgaze and downgaze.\n    - Preserved vestibulo-ocular (oculocephalic) reflex. This constellation defines a vertical supranuclear gaze palsy.\n- **Pharmacological Response:** Minimal clinical improvement on a standardized levodopa trial ($800$ mg/day for $8$ weeks).\n- **Autonomic Function:**\n    - No significant orthostatic hypotension (systolic blood pressure drop < $10$ mmHg).\n    - No urinary retention requiring catheterization.\n- **Neuroimaging (MRI):**\n    - Disproportionate midbrain atrophy with relative pontine preservation (\"hummingbird\" sign).\n    - No \"hot-cross bun\" sign in the pons.\n    - No marked putaminal rim hyperintensity.\n- **Cortical Function:**\n    - No cortical sensory deficits.\n    - No limb apraxia.\n    - No alien limb phenomena.\n- **Disease Course and Etiology:**\n    - No stepwise progression.\n    - MRI lacks confluent subcortical ischemic changes.\n- **Other Negatives:** No significant peripheral neuropathy or cerebellar ataxia on examination.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is evaluated against the established criteria:\n- **Scientifically Grounded:** The problem presents a detailed and coherent clinical vignette that is entirely consistent with established neurological science. The signs, symptoms, and radiological findings (e.g., supranuclear gaze palsy, \"hummingbird\" sign, poor levodopa response) are classic elements used in the differential diagnosis of atypical parkinsonian syndromes. The topic is central to the field of neurology.\n- **Well-Posed:** The problem provides sufficient, specific, and consistent information to allow for a differential diagnosis and to arrive at a single most likely answer among the given options.\n- **Objective:** The description uses precise, objective clinical terminology and quantitative data (e.g., levodopa dose, blood pressure drop) without resorting to subjective or ambiguous language.\n\n**Step 3: Verdict and Action**\nThe problem statement is scientifically sound, well-posed, objective, and internally consistent. It is a valid problem. The analysis will proceed to a solution.\n\n### DERIVATION OF THE SOLUTION\n\nThe provided clinical information points toward a specific diagnosis by including features highly characteristic of one condition while actively excluding others. The core task is to synthesize these findings.\n\n1.  **Core Syndrome:** The patient presents with parkinsonism, characterized by bradykinesia (slowness of movement) and rigidity (stiffness). However, several features suggest an \"atypical\" parkinsonian syndrome rather than idiopathic Parkinson's Disease (PD).\n\n2.  **Red Flags for Atypical Parkinsonism:**\n    *   **Symmetrical onset:** PD is classically asymmetric at onset.\n    *   **Early, severe postural instability:** Multiple falls within the first year (here, $6$ months) is a classic red flag. In PD, significant gait impairment and falls typically occur much later in the disease course.\n    *   **Poor response to levodopa:** A trial of up to $800$ mg/day is substantial. Minimal response strongly suggests a non-dopaminergic, postsynaptic pathology, characteristic of atypical syndromes.\n    *   **Specific eye movement abnormality:** The presence of a vertical supranuclear gaze palsy is a key localizing sign not found in PD.\n\n3.  **Differentiating Among Atypical Syndromes:**\n    *   **Progressive Supranuclear Palsy (PSP):** The patient's presentation is a textbook example of PSP, specifically the classic Richardson syndrome (PSP-RS). The cardinal features present are:\n        *   Early-onset postural instability with frequent unexplained backward falls.\n        *   Vertical supranuclear gaze palsy (impaired voluntary vertical saccades with preserved oculocephalic reflex).\n        *   Symmetrical axial rigidity.\n        *   Spastic dysarthria and dysphagia (implied by spastic dysarthria).\n        *   Poor levodopa response.\n        *   The \"hummingbird sign\" (or \"penguin silhouette sign\") on midsagittal MRI, reflecting severe atrophy of the midbrain tegmentum while the pons is relatively preserved, is highly specific for PSP.\n\n    *   **Multiple System Atrophy (MSA):** This diagnosis is effectively excluded by the stated lack of significant autonomic failure. MSA is defined by parkinsonism (MSA-P) or cerebellar ataxia (MSA-C) combined with early and severe autonomic failure (orthostatic hypotension meeting specific criteria—a systolic drop of $\\ge 20$ mmHg or diastolic drop of $\\ge 10$ mmHg—or urinary incontinence/retention). The patient's systolic BP drop is explicitly given as less than $10$ mmHg, and there is no urinary retention. The absence of the \"hot-cross bun\" sign on MRI further argues against MSA.\n\n    *   **Corticobasal Degeneration (CBD):** This diagnosis is excluded by the absence of its core features. CBD is characterized by striking asymmetry and prominent cortical signs, such as limb apraxia (inability to perform learned movements), cortical sensory loss, and/or the alien limb phenomenon. The patient's symptoms are symmetrical and lack these specific cortical deficits.\n\n    *   **Vascular Parkinsonism:** This is ruled out by the progressive nature of the decline (not stepwise) and the absence of confluent subcortical ischemic changes on brain MRI.\n\n**Conclusion:** The combination of early falls, symmetric axial parkinsonism, vertical supranuclear gaze palsy, and the characteristic \"hummingbird\" sign on MRI, in the context of a poor levodopa response and no significant autonomic or cortical dysfunction, makes Progressive Supranuclear Palsy (PSP), Richardson syndrome phenotype, the most likely diagnosis.\n\n### OPTION-BY-OPTION ANALYSIS\n\n**A. Progressive Supranuclear Palsy (PSP), Richardson syndrome phenotype**\nThis option aligns perfectly with the clinical picture. The key diagnostic pillars for PSP-RS are all present: early postural instability with falls ($< 1$ year), vertical supranuclear gaze palsy, and a poor levodopa response. The supportive feature of the \"hummingbird\" sign on MRI provides strong confirmatory evidence.\n**Verdict: Correct**\n\n**B. Parkinson’s Disease (PD)**\nThis diagnosis is inconsistent with the evidence. PD is typically characterized by asymmetric onset, a good initial response to levodopa, and the late development of postural instability. The presence of a vertical supranuclear gaze palsy is an exclusion criterion for a diagnosis of idiopathic PD.\n**Verdict: Incorrect**\n\n**C. Multiple System Atrophy–parkinsonian type (MSA-P)**\nThis diagnosis is contradicted by the explicit absence of significant autonomic failure. A defining criterion for MSA is severe autonomic dysfunction, which this patient does not have. The specific MRI and neuro-ophthalmologic findings (hummingbird sign, vertical supranuclear gaze palsy) point away from MSA and toward PSP.\n**Verdict: Incorrect**\n\n**D. Corticobasal Degeneration (CBD)**\nThis diagnosis is contradicted by the symmetrical nature of the parkinsonism and the absence of the characteristic cortical signs of CBD, such as apraxia, cortical sensory deficits, or alien limb phenomenon.\n**Verdict: Incorrect**\n\n**E. Vascular parkinsonism**\nThis diagnosis is excluded by the clinical course (progressive, not stepwise) and the MRI findings (lack of significant vascular changes). While gait dysfunction can be prominent, the other features in the vignette are not characteristic of vascular parkinsonism.\n**Verdict: Incorrect**",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Autonomic failure is a key separator in the differential diagnosis of parkinsonism, with neurogenic orthostatic hypotension (nOH) being a core feature of Multiple System Atrophy (MSA). This exercise provides a hands-on opportunity to apply the formal clinical criteria for nOH to bedside physiological measurements. By analyzing both blood pressure changes and the corresponding heart rate response, you will practice distinguishing the blunted baroreflex of autonomic failure from a normal physiological compensation.",
            "id": "4449620",
            "problem": "A $58$-year-old individual with rapidly progressive akinetic–rigid parkinsonism, early urinary and erectile dysfunction, and cerebellar ataxia is evaluated for possible Multiple System Atrophy (MSA). The differential diagnosis includes Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD). The patient reports lightheadedness after standing from supine. You perform standardized bedside measurements of blood pressure (BP) in millimeters of mercury (mmHg) and heart rate (HR) in beats per minute (bpm) after at least $5$ minutes supine rest, then at fixed intervals after active standing. Your task is to determine, using first principles of baroreflex physiology and accepted clinical definitions, which measurement pattern is most consistent with neurogenic orthostatic hypotension, defined by a sustained fall in BP within $3$ minutes of standing coupled with a blunted HR response.\n\nSelect all options that demonstrate a sustained drop of at least $20$ mmHg systolic or $10$ mmHg diastolic within $3$ minutes of standing with blunted HR increment, as would be expected in neurogenic orthostatic hypotension in MSA.\n\nA. Supine: BP $150/85$ mmHg, HR $62$ bpm; $1$ minute standing: BP $130/78$ mmHg, HR $64$ bpm; $3$ minutes standing: BP $128/76$ mmHg, HR $65$ bpm.\n\nB. Supine: BP $142/80$ mmHg, HR $70$ bpm; $1$ minute standing: BP $120/70$ mmHg, HR $92$ bpm; $3$ minutes standing: BP $118/68$ mmHg, HR $96$ bpm.\n\nC. Supine: BP $150/85$ mmHg, HR $64$ bpm; $1$ minute standing: BP $140/84$ mmHg, HR $80$ bpm; $3$ minutes standing: BP $138/82$ mmHg, HR $82$ bpm; $5$ minutes standing: BP $128/74$ mmHg, HR $84$ bpm.\n\nD. Supine: BP $135/78$ mmHg, HR $68$ bpm; $1$ minute standing: BP $118/70$ mmHg, HR $69$ bpm; $3$ minutes standing: BP $116/68$ mmHg, HR $70$ bpm.\n\nE. Supine: BP $155/95$ mmHg, HR $58$ bpm; $1$ minute standing: BP $120/75$ mmHg, HR $88$ bpm; $3$ minutes standing: BP $118/74$ mmHg, HR $86$ bpm.\n\nChoose all that apply.",
            "solution": "To solve this problem, we must apply the specific criteria for neurogenic orthostatic hypotension (nOH) provided in the problem description. nOH requires two conditions to be met:\n1.  **Orthostatic Hypotension (OH):** A sustained drop in blood pressure within 3 minutes of standing of at least $20$ mmHg systolic OR at least $10$ mmHg diastolic.\n2.  **Neurogenic Component:** A blunted heart rate (HR) response, indicating failure of the autonomic baroreflex. A common clinical heuristic for a blunted response is an HR increase of less than $0.5$ beats per minute for every $1$ mmHg drop in systolic blood pressure (i.e., $\\frac{\\Delta \\text{HR}}{\\Delta \\text{SBP}} < 0.5$).\n\nLet's analyze each option at the 3-minute mark after standing.\n\n**A. Supine: BP $150/85$ mmHg, HR $62$ bpm; 3 minutes standing: BP $128/76$ mmHg, HR $65$ bpm.**\n- **OH Check:**\n  - Systolic drop: $150 - 128 = 22$ mmHg ($\\ge 20$ mmHg). Criterion met.\n  - Diastolic drop: $85 - 76 = 9$ mmHg ($< 10$ mmHg).\n  - Since the systolic criterion is met, the patient has OH.\n- **Neurogenic Check:**\n  - HR increase: $65 - 62 = 3$ bpm.\n  - Ratio: $\\frac{\\Delta \\text{HR}}{\\Delta \\text{SBP}} = \\frac{3}{22} \\approx 0.14$.\n  - Since $0.14  0.5$, the HR response is blunted.\n- **Conclusion:** This option meets the criteria for nOH.\n\n**B. Supine: BP $142/80$ mmHg, HR $70$ bpm; 3 minutes standing: BP $118/68$ mmHg, HR $96$ bpm.**\n- **OH Check:**\n  - Systolic drop: $142 - 118 = 24$ mmHg ($\\ge 20$ mmHg). Criterion met.\n- **Neurogenic Check:**\n  - HR increase: $96 - 70 = 26$ bpm.\n  - Ratio: $\\frac{\\Delta \\text{HR}}{\\Delta \\text{SBP}} = \\frac{26}{24} \\approx 1.08$.\n  - Since $1.08 \\ge 0.5$, the HR response is robust, not blunted. This is characteristic of OH from non-neurogenic causes like dehydration.\n- **Conclusion:** This option does not meet the criteria for nOH.\n\n**C. Supine: BP $150/85$ mmHg, HR $64$ bpm; 3 minutes standing: BP $138/82$ mmHg, HR $82$ bpm.**\n- **OH Check:**\n  - Systolic drop: $150 - 138 = 12$ mmHg ($ 20$ mmHg).\n  - Diastolic drop: $85 - 82 = 3$ mmHg ($ 10$ mmHg).\n  - Neither criterion for OH is met within the 3-minute window.\n- **Conclusion:** This option does not show OH.\n\n**D. Supine: BP $135/78$ mmHg, HR $68$ bpm; 3 minutes standing: BP $116/68$ mmHg, HR $70$ bpm.**\n- **OH Check:**\n  - Systolic drop: $135 - 116 = 19$ mmHg ($ 20$ mmHg).\n  - Diastolic drop: $78 - 68 = 10$ mmHg ($\\ge 10$ mmHg). Criterion met.\n  - Since the diastolic criterion is met, the patient has OH.\n- **Neurogenic Check:**\n  - HR increase: $70 - 68 = 2$ bpm.\n  - Ratio: $\\frac{\\Delta \\text{HR}}{\\Delta \\text{SBP}} = \\frac{2}{19} \\approx 0.11$.\n  - Since $0.11  0.5$, the HR response is blunted.\n- **Conclusion:** This option meets the criteria for nOH.\n\n**E. Supine: BP $155/95$ mmHg, HR $58$ bpm; 3 minutes standing: BP $118/74$ mmHg, HR $86$ bpm.**\n- **OH Check:**\n  - Systolic drop: $155 - 118 = 37$ mmHg ($\\ge 20$ mmHg). Criterion met.\n- **Neurogenic Check:**\n  - HR increase: $86 - 58 = 28$ bpm.\n  - Ratio: $\\frac{\\Delta \\text{HR}}{\\Delta \\text{SBP}} = \\frac{28}{37} \\approx 0.76$.\n  - Since $0.76 \\ge 0.5$, the HR response is robust, not blunted.\n- **Conclusion:** This option does not meet the criteria for nOH.\n\nTherefore, options A and D are the only ones that demonstrate neurogenic orthostatic hypotension according to the given definition.",
            "answer": "$$\\boxed{AD}$$"
        },
        {
            "introduction": "To enhance diagnostic certainty, clinical neurology increasingly incorporates quantitative biomarkers derived from neuroimaging. This problem introduces the Magnetic Resonance Parkinsonism Index (MRPI), a powerful tool for discriminating Progressive Supranuclear Palsy (PSP). You will practice calculating this index from specific structural MRI measurements, gaining insight into how ratios of affected and spared brain regions provide an objective, powerful signature of the disease.",
            "id": "4449679",
            "problem": "Atypical parkinsonian syndromes such as Progressive Supranuclear Palsy (PSP), Multiple System Atrophy (MSA), and Parkinson’s disease (PD) show distinct and reproducible structural changes on brain Magnetic Resonance Imaging (MRI). Morphometric indices that are dimensionless and constructed from ratios of areas and linear widths are robust to intersubject scaling and facilitate discrimination among these syndromes. In PSP, there is well-documented atrophy of the midbrain and thinning of the superior cerebellar peduncles, whereas the pons area and the middle cerebellar peduncle are relatively less affected compared to PD and MSA. Starting from these widely accepted imaging observations and the principle that ratios of homologous measures provide normalization, define a dimensionless composite MRI-based index that integrates the relative pons-to-midbrain size and the relative middle-to-superior cerebellar peduncle width, known as the Magnetic Resonance Parkinsonism Index (MRPI). Then, compute this index for the following patient whose measurements were obtained in the mid-sagittal plane for areas and in the orthogonal plane for peduncle widths:\n\n- Midbrain area $A_{mb} = 101.3\\ \\mathrm{mm}^{2}$\n- Pons area $A_{p} = 479.8\\ \\mathrm{mm}^{2}$\n- Superior cerebellar peduncle width $w_{scp} = 2.41\\ \\mathrm{mm}$\n- Middle cerebellar peduncle width $w_{mcp} = 7.22\\ \\mathrm{mm}$\n\nExpress your final answer as a dimensionless number rounded to four significant figures. Do not include units in your final boxed answer.",
            "solution": "The problem requires the definition and calculation of the Magnetic Resonance Parkinsonism Index (MRPI), a dimensionless composite index used to help differentiate atypical parkinsonian syndromes. The definition must be derived from the provided principles of relative morphometry.\n\nFirst, let us establish the definition of the MRPI based on the given information. The goal is to create a dimensionless index that is sensitive to the structural changes characteristic of Progressive Supranuclear Palsy (PSP). The problem states that in PSP, there is atrophy of the midbrain (area denoted by $A_{mb}$) and thinning of the superior cerebellar peduncles (width denoted by $w_{scp}$). Conversely, the pons (area $A_{p}$) and the middle cerebellar peduncles (width $w_{mcp}$) are relatively spared.\n\nAn index designed to be elevated in PSP should therefore place the measures of the relatively preserved structures in the numerator and the measures of the atrophied structures in the denominator. This construction ensures the index value increases as the pathological changes of PSP become more pronounced.\n\nThe problem specifies two components to be integrated:\n1.  The \"relative pons-to-midbrain size\". This is a ratio of two areas. To reflect the relative preservation of the pons and atrophy of the midbrain in PSP, this ratio is defined as the pons area divided by the midbrain area:\n    $$ \\text{Ratio}_1 = \\frac{A_{p}}{A_{mb}} $$\n    This ratio is dimensionless, as it is an area divided by an area ($[\\text{length}]^2 / [\\text{length}]^2$).\n\n2.  The \"relative middle-to-superior cerebellar peduncle width\". This is a ratio of two widths. To reflect the relative preservation of the middle cerebellar peduncle and atrophy of the superior cerebellar peduncle in PSP, this ratio is defined as the middle cerebellar peduncle width divided by the superior cerebellar peduncle width:\n    $$ \\text{Ratio}_2 = \\frac{w_{mcp}}{w_{scp}} $$\n    This ratio is also dimensionless, as it is a length divided by a length ($[\\text{length}] / [\\text{length}]$).\n\nThe problem asks to \"integrate\" these two dimensionless ratios to form a single composite index, the MRPI. The most direct method to combine two independent ratios that both indicate the same underlying pathology is to multiply them. This enhances the discriminatory power of the resulting index. Therefore, the MRPI is defined as the product of these two ratios:\n$$ \\text{MRPI} = \\text{Ratio}_1 \\times \\text{Ratio}_2 = \\left( \\frac{A_{p}}{A_{mb}} \\right) \\times \\left( \\frac{w_{mcp}}{w_{scp}} \\right) $$\n\nNow, we can compute the value of the MRPI for the given patient data:\n- Midbrain area $A_{mb} = 101.3\\ \\mathrm{mm}^{2}$\n- Pons area $A_{p} = 479.8\\ \\mathrm{mm}^{2}$\n- Superior cerebellar peduncle width $w_{scp} = 2.41\\ \\mathrm{mm}$\n- Middle cerebellar peduncle width $w_{mcp} = 7.22\\ \\mathrm{mm}$\n\nSubstituting these values into the derived formula:\n$$ \\text{MRPI} = \\left( \\frac{479.8}{101.3} \\right) \\times \\left( \\frac{7.22}{2.41} \\right) $$\n\nFirst, we calculate the individual ratios:\n$$ \\frac{479.8}{101.3} \\approx 4.736426456 $$\n$$ \\frac{7.22}{2.41} \\approx 2.995850622 $$\n\nNext, we multiply these two results:\n$$ \\text{MRPI} \\approx 4.736426456 \\times 2.995850622 \\approx 14.1894980 $$\n\nThe problem requires the final answer to be rounded to four significant figures. The calculated value is $14.1894980...$. The fifth significant digit is $9$, which is greater than or equal to $5$, so we round up the fourth significant digit.\nThe resulting value is $14.19$.",
            "answer": "$$\\boxed{14.19}$$"
        }
    ]
}